Skip to main content
Premium Trial:

Request an Annual Quote

Vanderbilt, NFCR Building Proteomics Center to Study Cancer Dxs, Rxs

NEW YORK (GenomeWeb News) — Vanderbilt University Medical Center is building a center that will study how proteomics and molecular markers can help develop diagnostics and drugs for cancer, the school said today.
Vanderbilt’s Center for Proteomics and Drug Actions is funded by a $1 million, five-year grant from the National Foundation for Cancer Research and will be linked with seven other university research centers in the US, UK, and in China, Vanderbilt said.
The school said researchers at the center will work to “develop new technology that will reveal how drugs interact with protein targets, both therapeutic and the potential side-effects.”
The university said it sought to build the center after it recognized that proteomic tools can help discover molecular markers that may lead to diagnostics, drug targets, “new endpoints for accelerating clinical trials.”
The grant will be used in large part to extend research conducted by Vanderbilt researcher Larry Marnett, who has developed techniques to make drug agents bind tightly with targets to create markers that are easy to detect and extract.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.